July 9, 2019 Third long-acting injectable antipsychotic using MedinCell’s technology enters preclinical development Read press release
May 21, 2019 Shareholders audioconference and publication of the results for the 2018-2019 financial year, on June 4, 2019 Read press release
April 26, 2019 MedinCell wins the #LetsgoFrance 2019 trophy in the category “France, a model of sustainable economy” (in French) Read press release
March 11, 2019 MedinCell demonstrates in vivo the efficacy of the first injectable combining surgical anesthesia and 3 days opioid free postoperative pain management Read press release
January 24, 2019 MedinCell receives 2nd part of the grant from the Bill & Melinda Gates Foundation Read press release